Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
-
Published:2023-07
Issue:
Volume:207
Page:106267
-
ISSN:1046-5928
-
Container-title:Protein Expression and Purification
-
language:en
-
Short-container-title:Protein Expression and Purification
Author:
Qiao Huarui,
Li Lingyun,
Wang Lu,
Yu Haijun,
Hu Fangzheng,
Zhou Xin,
Yang Hongzhao,
Xu Jianfeng,
Meng Xiangjing,
Geng YongORCID,
Dai Yuanyuan
Reference30 articles.
1. The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat;Arshad Ali;J. infection public health,2020
2. Spike mutation D614G alters SARS-CoV-2 fitness;Plante;Nature,2021
3. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France;Bal;Euro Surveill. : bulletin Europeen sur les maladies transmissibles European communicable disease bulletin,2021
4. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance;Chen;J. Chem. Inf. Model.,2022
5. Papain-like proteases as coronaviral drug targets: current inhibitors, opportunities, and limitations;Petushkova;Pharmaceuticals,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献